COMORBIDITIES

Clinical trials for COMORBIDITIES explained in plain language.

Never miss a new study

Get alerted when new COMORBIDITIES trials appear

Sign up with your email to follow new studies for COMORBIDITIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

Two-Drug combo may boost outcomes in High-Risk PAH patients

Disease control Not yet recruiting

This study looks at people newly diagnosed with pulmonary arterial hypertension (PAH) who also have at least two heart-related conditions. It compares starting treatment with two oral medications (tadalafil and ambrisentan) versus just one. The goal is to see if the combination h…

Matched conditions: COMORBIDITIES

Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Apr 30, 2026 15:51 UTC

COMORBIDITIES

Get alerted when new COMORBIDITIES trials appear

Two-Drug combo may boost outcomes in High-Risk PAH patients